Even though the main mechanism of PNPLA3 in vivo is not completely understood, Romeo et al. described its influence on the development of hepatic steatosis and hepatic necroinflammation, thereby increasing the susceptibility for non-alcoholic fatty liver disease (NAFLD) [18]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.